New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2014
09:12 EDTACH, EMR, ZNGA, PSMI, TTWO, PSEC, NUS, ARMH, BSX, FURX, ENTG, KORS, ATMI, AEIS, JCPOn The Fly: Pre-market Movers
HIGHER: Michael Kors (KORS), up 21% after Q3 earnings beat expectations, company raises guidance... Furiex (FURX), up 124% after reporting top-line results for its Phase III trials evaluating its irritable bowel syndrome treatment... Zynga (ZNGA), up 7% following upgrade at UBS... J.C. Penney (JCP), up 3.5% after reporting positive Q4 comparable store sales... Nu Skin (NUS), up 2% after Q4 EPS and revenue view top expectations... ATMI (ATMI), up 25% after peer Entegris (ENTG) agrees to acquire company for $34.00 per share. Entegris shares also up 17% after deal announcement, while others in the sector, such as Advanced Energy Industries (AEIS) also rose... DOWN AFTER EARNINGS: ARM Holdings (ARMH), down 6.8%... Arch Coal (ACI), down 1.8%. ALSO LOWER: Take-Two (TTWO), down 6% after earnings report, downgrades at Wedbush and Benchmark... Peregrine (PSMI), down 16% after earnings, downgrades at Needham and JPMorgan.
News For KORS;JCP;ATMI;ENTG;AEIS;NUS;ZNGA;FURX;PSEC;EMR;BSX;TTWO;ACH;ARMH;PSMI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
November 21, 2014
14:08 EDTTTWOHacker group releases login info for three gaming networks, CNet says
Subscribe for More Information
November 20, 2014
07:31 EDTBSXBoston Scientific should be bought on weakness, says RBC Capital
Subscribe for More Information
07:19 EDTKORSMichael Kors holiday catalog pricing up 11%, says Piper Jaffray
Piper Jaffray says its analysis shows the weighted average pricing for the Michael Kors Holiday catalog was $242, up 11% from last year. The firm adds the catalog contains new handbag silhouettes introductions including Dillon & Sutton. Piper continues to view Michael Kors as its top Holiday pick and keeps an Overweight rating on the name with a $98 price target.
November 19, 2014
16:24 EDTEMREmerson files automatic mixed securities shelf
Subscribe for More Information
12:11 EDTBSXBoston Scientific says Synergy stent met primary endpoint in trial
In the first successful U.S. pivotal trial of a bioabsorbable polymer stent, the Boston Scientific SYNERGY Everolimus-Eluting Bioabsorbable Polymer Platinum Chromium Coronary Stent System met its primary endpoint in this non-inferiority study, which evaluated the one-year rate of target lesion failure. Additionally, favorable rates for key secondary endpoints were observed with the SYNERGY Stent. Dean Kereiakes, M.D., F.A.C.C., F.S.C.A.I., the principal investigator for the EVOLVE II Trial, presented the study results today in a Late Breaking Clinical Trial session at the American Heart Association Scientific Session 2014 in Chicago. Key findings for the SYNERGY Stent from the EVOLVE II Trial include the following: At 12 months, the TLF rate was 6.4% per protocol and 6.7% for intent-to-treat. Stent Thrombosis was rare, with Definite or Probable ST occurring in only 0.4% of patients through one year. No Definite ST occurred after 24 hours.
10:25 EDTJCPOptions with decreasing implied volatility
Subscribe for More Information
10:00 EDTNUSOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:30 EDTBSXJohnson & Johnson, Boston Scientific trial set to start tomorrow, Reuters says
Subscribe for More Information
06:14 EDTNUSNu Skin initiated with a Neutral at BTIG
Subscribe for More Information
November 18, 2014
16:05 EDTAEISAdvanced Energy announces CFO transition
Subscribe for More Information
11:35 EDTBSXBoston Scientific November volatility elevated into investor day
Subscribe for More Information
10:29 EDTPSECOptions with increasing implied volatility: YHOO PSEC
Subscribe for More Information
10:20 EDTJCPOptions with decreasing implied volatility
Subscribe for More Information
07:37 EDTBSXStifel to hold a conference
Subscribe for More Information
07:30 EDTKORSMorgan Stanley to hold a conference
Subscribe for More Information
06:08 EDTBSXBoston Scientific to host investor meeting
Investor meeting to be held on November 19 at 2 pm. Webcast Link
November 17, 2014
14:21 EDTJCPEarnings Preview: Home Depot shares up over 17% since last earnings report
Subscribe for More Information
13:09 EDTZNGAZynga's Pincus, directors must face lawsuit over 'lockup' sales, Reuters says
Subscribe for More Information
12:03 EDTJCPOptions with decreasing implied volatility
Subscribe for More Information
09:08 EDTBSXBoston Scientific announces first U.S. procedures with Symphion completed
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use